Neumora Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $317.0M
Liabilities Breakdown FY2024
Total Liabilities: $29.9M
Asset Breakdown
Total Assets: $317.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $142.1M | 44.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.1M | 0.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $173.7M | 54.8% |
Liabilities Breakdown
Total Liabilities: $29.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.3M | 11.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $26.6M | 88.9% |